306 related articles for article (PubMed ID: 10474521)
1. Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach.
Lagendijk JH; Mullink H; van Diest PJ; Meijer GA; Meijer CJ
J Clin Pathol; 1999 Apr; 52(4):283-90. PubMed ID: 10474521
[TBL] [Abstract][Full Text] [Related]
2. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites.
Lagendijk JH; Mullink H; Van Diest PJ; Meijer GA; Meijer CJ
Hum Pathol; 1998 May; 29(5):491-7. PubMed ID: 9596273
[TBL] [Abstract][Full Text] [Related]
3. Value of a panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma.
Torenbeek R; Lagendijk JH; Van Diest PJ; Bril H; van de Molengraft FJ; Meijer CJ
Histopathology; 1998 Jan; 32(1):20-7. PubMed ID: 9522212
[TBL] [Abstract][Full Text] [Related]
4. Metastatic adenocarcinoma to the brain: an immunohistochemical approach.
Perry A; Parisi JE; Kurtin PJ
Hum Pathol; 1997 Aug; 28(8):938-43. PubMed ID: 9269830
[TBL] [Abstract][Full Text] [Related]
5. Perianal Paget's disease: distinguishing primary and secondary lesions using immunohistochemical studies including gross cystic disease fluid protein-15 and cytokeratin 20 expression.
Nowak MA; Guerriere-Kovach P; Pathan A; Campbell TE; Deppisch LM
Arch Pathol Lab Med; 1998 Dec; 122(12):1077-81. PubMed ID: 9870855
[TBL] [Abstract][Full Text] [Related]
6. Value of gross cystic disease fluid protein-15 in distinguishing metastatic breast carcinomas among poorly differentiated neoplasms involving the ovary.
Monteagudo C; Merino MJ; LaPorte N; Neumann RD
Hum Pathol; 1991 Apr; 22(4):368-72. PubMed ID: 2050370
[TBL] [Abstract][Full Text] [Related]
7. Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary.
Wauters CC; Smedts F; Gerrits LG; Bosman FT; Ramaekers FC
Hum Pathol; 1995 Aug; 26(8):852-5. PubMed ID: 7543441
[TBL] [Abstract][Full Text] [Related]
8. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma.
Berezowski K; Stastny JF; Kornstein MJ
Mod Pathol; 1996 Apr; 9(4):426-9. PubMed ID: 8729984
[TBL] [Abstract][Full Text] [Related]
9. Necrosis in 84 ovarian carcinomas: a morphologic study of primary versus metastatic colonic carcinoma with a selective immunohistochemical analysis of cytokeratin subtypes and carcinoembryonic antigen.
DeCostanzo DC; Elias JM; Chumas JC
Int J Gynecol Pathol; 1997 Jul; 16(3):245-9. PubMed ID: 9421090
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites.
Kaufmann O; Deidesheimer T; Muehlenberg M; Deicke P; Dietel M
Histopathology; 1996 Sep; 29(3):233-40. PubMed ID: 8884351
[TBL] [Abstract][Full Text] [Related]
11. Value of GCDFP-15 (BRST-2) as a specific immunocytochemical marker for breast carcinoma in cytologic specimens.
Fiel MI; Cernaianu G; Burstein DE; Batheja N
Acta Cytol; 1996; 40(4):637-41. PubMed ID: 8693878
[TBL] [Abstract][Full Text] [Related]
12. Villin, cytokeratin 7, and cytokeratin 20 expression in pulmonary adenocarcinoma with ultrastructural evidence of microvilli with rootlets.
Tan J; Sidhu G; Greco MA; Ballard H; Wieczorek R
Hum Pathol; 1998 Apr; 29(4):390-6. PubMed ID: 9563790
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of breast specific antigens and cytokeratins in metastatic breast carcinoma in the liver.
Akasofu M; Kawahara E; Kurumaya H; Nakanishi I
Acta Pathol Jpn; 1993 Dec; 43(12):736-44. PubMed ID: 7509105
[TBL] [Abstract][Full Text] [Related]
14. Adenocarcinoma in females detected in serous effusions. Cytomorphologic aspects and immunocytochemical reactivity to cytokeratins 7 and 20.
Longatto Filho A; Bisi H; Alves VA; Kanamura CT; Oyafuso MS; Bortolan J; Lombardo V
Acta Cytol; 1997; 41(4):961-71. PubMed ID: 9250286
[TBL] [Abstract][Full Text] [Related]
15. Colonic adenocarcinoma metastatic to the thyroid gland: a case report with immunohistochemical investigation.
Kim CH; Park YW; Ayala AG; Ro JY
J Korean Med Sci; 1999 Aug; 14(4):455-9. PubMed ID: 10485629
[TBL] [Abstract][Full Text] [Related]
16. [Serous cystadenocarcinoma of the ovary with simultaneous breast metastases. Description of a case].
Manini C; Pietribiasi F; Sapino A; Donadio S
Pathologica; 1998 Apr; 90(2):152-5. PubMed ID: 9619059
[TBL] [Abstract][Full Text] [Related]
17. The immunohistochemical discrimination of endometrioid adenocarcinomas.
Dabbs DJ; Sturtz K; Zaino RJ
Hum Pathol; 1996 Feb; 27(2):172-7. PubMed ID: 8617459
[TBL] [Abstract][Full Text] [Related]
18. Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas.
Loy TS; Calaluce RD
Am J Clin Pathol; 1994 Dec; 102(6):764-7. PubMed ID: 7528468
[TBL] [Abstract][Full Text] [Related]
19. Thyroid transcription factor-1 and cytokeratins 7 and 20 in pulmonary and breast carcinoma.
Harlamert HA; Mira J; Bejarano PA; Baughman RP; Miller MA; Whitsett JA; Yassin R
Acta Cytol; 1998; 42(6):1382-8. PubMed ID: 9850647
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site.
Brown RW; Campagna LB; Dunn JK; Cagle PT
Am J Clin Pathol; 1997 Jan; 107(1):12-9. PubMed ID: 8980361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]